Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer
Clinical trial NCT05751629 · COMPLETED
Trial details
- NCT number
- NCT05751629
- Sponsor
- Tesaro, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2022-04-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.